Francesco Rossi
- Pharmacology top 5%
- Oncology top 10%
- Surgery
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Annalisa CapuanoGiuseppe PaolissoConcetta RafanielloMichele D’AmicoCristina ScavoneAnnamaria MascoloS DragoniLiberata Sportiello
- Topics
- Pharmaceutical studies and practices (13 papers)Pharmacovigilance and Adverse Drug Reactions (8 papers)Synthesis and biological activity (6 papers)
- Partner nations
- ItalyUnited StatesDenmark
In The Last Decade
Francesco Rossi
103 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 132
- Pharmacology 287
- Oncology 266
- Surgery 265
- Molecular Biology 219
- Endocrinology, Diabetes and Metabolism 219
Countries citing papers authored by Francesco Rossi
This map shows the geographic impact of Francesco Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Rossi more than expected).
Fields of papers citing papers by Francesco Rossi
This network shows the impact of papers produced by Francesco Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Rossi. The network helps show where Francesco Rossi may publish in the future.
Co-authorship network of co-authors of Francesco Rossi
This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Rossi. A scholar is included among the top collaborators of Francesco Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Rossi. Francesco Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 2 | |
| 5 | 15 | |
| 6 | 1 | |
| 7 | 33 | |
| 8 | 2 | |
| 9 | 14 | |
| 10 | 7 | |
| 11 | 11 | |
| 12 | 2 | |
| 13 | 10 | |
| 14 | Incretin-based therapies and cancer risk: a review of recent literature safety data | 2 |
| 15 | 3 | |
| 16 | 27 | |
| 17 | [Hypersensitivity reactions to chemotherapeutic antineoplastic agents]. | 10 |
| 18 | 6 | |
| 19 | 3 | |
| 20 | La previdenza sociale | 0 |
About Francesco Rossi
Francesco Rossi is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Geriatrics and Gerontology, having authored 112 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (13 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Synthesis and biological activity (6 papers). The work is most often cited by research in Toxicology (146 citations), Pharmacology (287 citations) and Endocrinology, Diabetes and Metabolism (219 citations). Francesco Rossi has collaborated with scholars based in Italy, United States and Denmark. Frequent co-authors include Annalisa Capuano, Giuseppe Paolisso, Concetta Rafaniello, Michele D’Amico, Cristina Scavone, Annamaria Mascolo, S Dragoni, Liberata Sportiello, Raffaele Marfella and Francesca Rossi. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.